Giving The Gov't Drug Patent March-In Authority Is Bad Policy
By Wayne Winegarden · December 13, 2023, 5:15 PM EST
In early December, the Biden administration announced a proposal on exercising march-in rights on taxpayer-funded drugs and other inventions that allows prices to "be a factor in considering whether a drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login